Skip to main content
OpenTrials
Completed

NCT Number: NCT05258916

Contribution of a Nurse Consultation in the Follow-up of At-risk Newborn at Maternity Discharged

The postnatal period is a critical phase involving important physiological, psychological and social changes. Pediatric nurses could be a crucial actor in the follow-up of at-risk newborn, in collaboration with other health professionals and contribute to a reduction in pediatric emergency department (PED) visits and/or hospitalization in first weeks of life. To describe population of at-risk newborns who attended a nurse consultation after discharge from a type 3 maternity hospital and to evaluate the impact of a post-hospitalization nurse consultation for at-risk newborns on PED visits and hospitalizations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

1 day and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, 91106, France

About this study

The postnatal period is a critical phase involving important physiological, psychological and social changes. In 2013, WHO recommends at least three postnatal contacts on day 3, between days 7 and 14, and six weeks after birth. Despite these recommendations, pediatric emergency department (PED) visits for newborns are constantly increasing. Some studies have shown that most of these visits were related to nonserious diseases, mainly due to a lack of knowledge and information. At the same time, some high-risk newborns have been identified as likely to be admitted to PED and subsequently hospitalized. All these findings highlight the great need for education and parental support by health staff from the time of maternity discharged, particularly when certain high-risk conditions are identified.

In France, guidelines on maternity discharge after childbirth include pediatric nurses as professionals involved in postnatal follow-up. Pediatric nurses could be a crucial actor in the follow-up of at-risk newborn, in collaboration with other health professionals and contribute to a reduction in PED visits and/or hospitalization in first weeks of life.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All at-risk newborns addressed to nurse consultation after discharge from maternity hospital.
  • All at-risk newborns discharged home after hospitalization at birth in the neonatal medicine department.

Exclusion criteria

  • Newborns discharged with home hospitalization
  • Consultation for hearing screening, blood testing or injection (vaccines or palivizumab).
  • Newborns referred by pediatrics department, PED or by exterior professionals.
  • Non-at-risk newborns hospitalized for other reasons (biological anoxia, early neonatal bacterial infection, transient tachypnea, monitoring)

Treatment and study plan

Nurse consultation

Procedure

nurse consultation carried out within two weeks after maternity discharged

Primary outcomes

  1. PED visits at 2 weeks

    Time frame: 2 weeks after discharge of maternity hospital

    Number and causes of PED visits

Secondary outcomes

  1. PED visits at 3 months

    Time frame: 3 months after discharge of maternity hospital

    Number and causes of PED visits

  2. Hospitalization

    Time frame: 3 months after discharge of maternity hospital

    Number and causes of hospitalizations

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Sud Francilien

Other

Registry information

Official study title

Feasibility and Contribution of a Nurse Consultation in the Follow-up of At-risk Newborn at Maternity Discharged: 3-year Experience in a Tertiary Center.

Acronym: NURCO-NEO

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Feb 28, 2022
Registry last updated
Aug 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.